• LAST PRICE
    2.4500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0000/ 0
  • Ask / Lots
    3.6000/ 1
  • Open / Previous Close
    0.0000 / 2.4500
  • Day Range
    ---
  • 52 Week Range
    Low 1.8500
    High 7.1500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.55
TimeVolumeLEXX
09:32 ET1002.535
10:14 ET2002.49
10:15 ET2002.535
12:05 ET1702.54
12:48 ET3332.53
01:51 ET3002.57
02:00 ET8002.5374
02:04 ET7002.53
02:20 ET6002.52
02:29 ET4002.5
03:43 ET4012.46
03:45 ET5202.46
03:48 ET5202.46
03:50 ET3002.4995
03:57 ET27002.45
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLEXX
Lexaria Bioscience Corp
14.3M
-2.0x
---
United StatesSBFM
Sunshine Biopharma Inc
15.6M
-0.5x
---
United StatesNLBS
Nutralife Biosciences Inc
12.4M
-2.7x
---
United StatesTTNP
Titan Pharmaceuticals Inc
15.6M
-1.3x
---
United StatesCYTH
Cyclo Therapeutics Inc
14.6M
-1.2x
---
United StatesAKAN
Akanda Corp
15.7M
-1.0x
---
As of 2022-10-05

Company Information

Lexaria Bioscience Corp. is a Canada-based global innovator in drug delivery platforms. The Company’s patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting oral delivery. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1-2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company operates through two segments: Intellectual Property and Products.

Contact Information

Headquarters
100 - 740 MCCURDY ROADKELOWNA, BC, Canada V1X 2P7
Phone
250-765-6424
Fax
604-685-7602

Executives

Chairman of the Board, Chief Executive Officer
Christopher Bunka
President, Director
John Docherty
Chief Financial Officer
Gregory Downey
Independent Director
Nicholas Baxter
Independent Director
Ted Mckechnie

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.3M
Revenue (TTM)
$175.3K
Shares Outstanding
6.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.18
EPS
$-1.21
Book Value
$2.32
P/E Ratio
-2.0x
Price/Sales (TTM)
81.8
Price/Cash Flow (TTM)
---
Operating Margin
-4,092.63%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.